Pakistani drugmakers eyeing Azerbaijan for JV manufacturing deals

Pakistan drug manufacturers are looking for joint ventures in Azerbaijan.

The Pakistani ambassador in Azerbaijan said several pharmaceutical companies from his country are looking to develop joint ventures in drug production in the country.

Khan Mohmand said Pakistan’s growing pharmaceutical industry is eyeing Azerbaijan for partnerships. In addition to drug manufacturing, Azerbaijan could also import surgical goods and medical instruments from Pakistan, he told Trend.

"They plan to create joint venture in the Pirallahi Industrial Zone, which offers tax reliefs," he said.

Cambrex Webinar

Understanding the Importance of Crystallization Processes to Avoid Unnecessary Cost, Risk and Development Delays

Wednesday, May 27, 2020 | 10am ET / 7am PT

A well-developed crystallization process can produce suitable particles that can facilitate consistent filtration, drying and formulation of the API and allow confident and reliable manufacturing of the final drug product, while avoiding unnecessary cost, risk and development delays.

Currently, there are three pharma manufacturing plants under construction in the Pirallahi Industrial Park in Azerbaijan, which was created in 2016. Two of those facilities are part of joint ventures that include R-Pharm, a Russian company, and Tamin Pharmaceutical Investment Company of Iran.

Pakistan has about 400 pharmaceutical manufacturing facilities, including about 25 that are operated by multinational corporations. The country’s pharmaceutical industry meets around 70% of Pakistan’s demand for finished medicine.

Read more on

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.